Literature DB >> 9605421

Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.

K Kim1, S Y Jung, D K Lee, J K Jung, J K Park, D K Kim, C H Lee.   

Abstract

Surfactin inhibits platelet and spleen cytosolic 100 kDa phospholipase A2 (PLA2). In contrast, this same compound enhances rat platelet group II PLA2 activity by approximately 2-fold and slightly increases group I PLA2 activity from porcine pancreas and Naja naja venom in vitro. Surfactin does not affect a Ca2+ -independent PLA2 partially purified from bovine brain. Thus, this compound inhibits selectively the cytosolic form of PLA2. Based on in vitro studies utilizing preincubation of surfactin with the enzyme, dialysis, and increased concentrations of substrates, the inhibitory effect of surfactin appears to be due to a direct interaction with the enzyme. Linear regression analysis of the linear portion of a concentration-response curve reveals an IC50 of 8.5 microM. To further determine the inhibitory pattern, a Dixon plot was constructed to show that the inhibition by surfactin is competitive, but not uncompetitive, with an inhibition constant of Ki = 4.7 microM in 50 mM Tris-HCl buffer, pH 8.0, at 37 degrees. Surfactin blocked non-stimulated and calcium ionophore A23187-stimulated release of arachidonic acid from monkey kidney CV-1 cells, which contain a cytosolic 100 kDa PLA2 as the major activity, as shown in an anionic exchange DEAE-5PW high performance liquid chromatography profile and western blotting analysis. Surfactin ameliorated inflammation induced by several chemicals. That is, it exhibited in vivo anti-inflammatory activity in several tested inflammatory reactions including 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear edema, carrageenan-induced rat paw edema, and acetic acid-induced mouse writhing. These results demonstrate that surfactin is a selective inhibitor for cytosolic PLA2 and a putative anti-inflammatory agent through the inhibitory effect produced by direct interaction with cytosolic PLA2, and that inhibition of cytosolic PLA2 activity may suppress inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605421     DOI: 10.1016/s0006-2952(97)00613-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  Production and Biomedical Applications of Probiotic Biosurfactants.

Authors:  Anila Fariq; Ayesha Saeed
Journal:  Curr Microbiol       Date:  2016-01-07       Impact factor: 2.188

2.  Potential anti-inflammatory actions of the elmiric (lipoamino) acids.

Authors:  Sumner H Burstein; Jeffrey K Adams; Heather B Bradshaw; Cristian Fraioli; Ronald G Rossetti; Rebecca A Salmonsen; John W Shaw; J Michael Walker; Robert E Zipkin; Robert B Zurier
Journal:  Bioorg Med Chem       Date:  2007-03-13       Impact factor: 3.641

3.  Regulation of adhesion of AML14.3D10 cells by surface clustering of beta2-integrin caused by ERK-independent activation of cPLA2.

Authors:  Shigeharu Myou; Xiangdong Zhu; Evan Boetticher; Yimin Qin; Saori Myo; Angelo Meliton; Anissa Lambertino; Nilda M Munoz; Kimm J Hamann; Alan R Leff
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

4.  Characterization and online detection of surfactin isomers based on HPLC-MS(n) analyses and their inhibitory effects on the overproduction of nitric oxide and the release of TNF-α and IL-6 in LPS-induced macrophages.

Authors:  Jin-Shan Tang; Feng Zhao; Hao Gao; Yi Dai; Zhi-Hong Yao; Kui Hong; Jia Li; Wen-Cai Ye; Xin-Sheng Yao
Journal:  Mar Drugs       Date:  2010-10-11       Impact factor: 5.118

Review 5.  Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review.

Authors:  Manoj Kumar Sarangi; Sasmita Padhi; L D Patel; Goutam Rath; Sitansu Sekhar Nanda; Dong Kee Yi
Journal:  J Drug Deliv Sci Technol       Date:  2022-09-06       Impact factor: 5.062

Review 6.  Biophysical approaches for exploring lipopeptide-lipid interactions.

Authors:  Sathishkumar Munusamy; Renaud Conde; Brandt Bertrand; Carlos Munoz-Garay
Journal:  Biochimie       Date:  2020-01-21       Impact factor: 4.079

Review 7.  Recent Advances in Biomedical, Therapeutic and Pharmaceutical Applications of Microbial Surfactants.

Authors:  Chiara Ceresa; Letizia Fracchia; Emanuele Fedeli; Chiara Porta; Ibrahim M Banat
Journal:  Pharmaceutics       Date:  2021-03-30       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.